Genetic ablation or pharmacological targeting of C5 [6, 7] or C5aR1 [3, 8, 9] during allergen sensitization resulted in aggravation of the allergic asthma phenotype, suggesting that C5aR1 protects from the development of allergic asthma. The gene discussed is C5; the disease is allergic asthma.